During the past decade, Spokane Digestive Disease Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Spokane Digestive Disease Center" are "Conscious Sedation" (1 trials), "Crohn's Disease" (1 trials), "Hepatitis C, Chronic" (1 trials), "Irritable Bowel Syndrome" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Spokane Digestive Disease Center" in a lesser frequency.

Most popular intervention types in "Spokane Digestive Disease Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "AQUAVAN® (fospropofol disodium) Injection" (1 trials), "Adalimumab" (1 trials), "Encapsulated Mesalamine Granules (eMG)" (1 trials), "ISIS 14803, peginterferon alfa, ribavirin" (1 trials) and "Midazolam HCI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spokane Digestive Disease Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Spokane Digestive Disease Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Spokane Digestive Disease Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spokane Digestive Disease Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".